Abstract
Purpose: To compare serum concentrations of lipoproteins and apolipoproteins in insulin-dependent diabetic patients with and without retinopathy.
Methods: A cross-sectional study was performed on 42 diabetic adolescents and young adults with different degrees of retinopathy. The mean ± SD age of the patient was 21.1 years (range 12.8-27.9 years); their mean duration of diabetes was 12.3 years (range 7.1-19.9 years). Their glycosylated haemoglobin (HbA1c) and fructosamine were respectively 10.2% (8.2-15.4%) and 280.8 mol/1 (202.1-458.5 mol/l). Forty-two diabetics without retinopathy similar to the study population as regards age, sex, duration of disease, HbA1c and microalbuminuria values, and 42 healthy subjects, served as controls.
Results: Serum lipid and lipoprotein concentrations were not different from those of healthy controls in patients either with or without retinopathy. The diabetic patients were subdivided in two groups according to the degree of their retinopathy: background and preproliferative/proliferative retinopathy. Patients with preproliferative/proliferative retinopathy were found to have significantly higher lipoprotein (a) values than the other group (background, 73.3 IU/1; preproliferative/proliferative, 205.9 IU/1; p0.001).
Conclusion: The increase in lipoprotein (a) levels might play a role in the development of severe retinopathy.
Similar content being viewed by others
Article PDF
References
Chiumello G, Bognetti E, Meschi E, Carrà M, Balzano E . Early diagnosis of subclinical complications in insulin dependent diabetic children and adolescents. J Endocrinol Invest 1989;12(Suppl 3):101–4.
Rand LI, Krolewski AS, Aiello LM, Warram JH, Baker RS, Maki T . Multiple factors in the prediction of risk of proliferative diabetic retinopathy. N Engl J Med 1985;313:1433–7.
Dahl-JØrgensen K, Brinchmann-Hansen O, Hanssen KF, Ganes T, Kieruf P, Smeland E, et al. Effect of near normoglycemia for two years on progression of early diabetic retinopathy, nephropathy and neuropathy: the Oslo Study. BMJ 1986;29:1195–9.
Morisaki N, Yokote K, Tashiro J, Inadera H, Kobayashi J, Kanzaki T, et al. Lipoprotein (a) is a risk factor for diabetic retinopathy in the elderly. J Am Geriatr Soc 1994;42:965–7.
Vannini P, Ciavarella A, Flammini M . Lipid abnormalities in insulin-dependent diabetic patients with albuminuria. Diabetes Care 1984;7:151–4.
Dullaart RPF, Dikkeschei LD, Doorenbos H . Alterations in serum lipids and apoliproteins in male Type 1 (insulin-dependent) diabetic patients with microalbu-minuria. Diabetologia 1989;32:685–9.
Sosenko JM, Breslow JL, Miettinen OS, Gabbay KH . Hyperglycemia and plasma lipid levels: a prospective study of young insulin-dependent diabetic patients. N Engl J Med 1980;302:650–4.
Durrington PN . Serum high density lipoprotein cholesterol in diabetes mellitus: an analysis of factors which influence its concentration. Clin Chim Acta 1980;104:11–23.
Eckel RH, Albers JJ, Cheung MC, Wahl PW, Lindgren FT, Bierman EL . High density lipoprotein composition in insulin dependent diabetes mellitus. Diabetes 1981;30:132–8.
Lopes-Virella MF, Wohltmann HJ, Loadholtt CB, Buse MG . Plasma lipids and lipoproteins in young insulin-dependent diabetic patients: relationship with control. Diabetologia 1981;21:216–23.
Laakso M, Voutilainen E, Sarlund H, Aro A, Pyorala K, Penttila I . Inverse relationship of serum HDL and HDL2 cholesterol to C-peptide level in middle-aged insulin-treated diabetics. Metabolism 1985;34:715–20.
Winocur PH, Durrington DN, Ishola M, Andersen DC . Lipoprotein abnormalities in insulin-dependent diabetes mellitus. Lancet 1986;I:1176–8.
Weisweiler P, Schwandt P . Type 1 (insulin-dependent) versus Type 2 (non-insulin-dependent) diabetes mellitus: characterisation of serum lipoprotein alterations. Eur J Clin Invest 1987;17:87–91.
Agardh CD, Agardh E, Bauer B, Nilsson-Ehle P . Plasma lipids and lipoproteins in diabetics with and without proliferative retinopathy. Acta Med Scand 1988;223:165–9.
Dihr SP, Dahiya R, Ram J, Dash RJ, Chakravarti RN . Serum lipoprotein cholesterol profile in diabetic retinopathy. Indian J Ophthalmol 1984;32:89–91.
Maioli M, Tonolol G, Pacifico A, Ciccarese M, Brizzi P, Kohner EM, Porta M . Raised serum apolipoprotein (a) in active diabetic retinopathy. Diabetologia 1993;36:88–90.
Laakso M, Sarlund H, Ehnholm C, Voutilainen E, Aro A, Pyörälä K . Relationship between postheparin plasma Upases and high-density lipoprotein cholesterol in different types of diabetes. Diabetologia 1987;30:703–6.
Brown GC, Ridley M, Haas D, Lucier AC, Sarin LK . Lipemic diabetic retinopathy. Ophthalmology 1984;91:1490–505.
Constable IJ, Welborn TA, Cooper RL . Medical correlates and diabetic retinopathy and nephropathy in diabetes. Diabetes 1980;100:78–82.
Kissebah AH, Kohner EM, Lewis B, Sidding YK, Lowy YK, Fraser TR . Plasma lipids and glucose/insulin relationship in non-insulin-requiring diabetics with and without retinopathy. Lancet 1975;I:1104–8.
Mohan R, Mohan V, Susheela L, Ramachandran A, Viswanathan M . Increased LDL cholesterol in non-insulin-dependent diabetics with maculopathy. Acta Diabetol 1984;21:85–9.
Jialal I, Joubert SM . The biochemical profile in Indian patients with non-insulin-dependent diabetes in the young with retinopathy. Diabet Metab 1985;11:262–5.
Sinav S, Onelge MA, Onelge S, Sinva B . Plasma lipid and lipoproteins in retinopathy of type 1 (insulin-dependent) diabetic patients. Ann Ophthalmol 1993;25:64–6.
Hanna AK, Roy M, Zinman B . An evaluation of factors associated with proliferative diabetic retino-pathy. J Clin Invest 1985;8:109–16.
Weber B, Burger W, Hartmann R, Hövener G, Malchus R, Oberdisse U . Risk factors for the development of retinopathy in children and adolescents with Type 1 (insulin-dependent) diabetes mellitus. Diabe-tologia 1986;29:23–9.
Bhatnagar D, Ishola M, Arrol S, Durrington PN . Lipoprotein (a) and microvascular disease in Type 1 (insulin-dependent) diabetes. Diabetic Med 1991;8:922–7.
Dullaart RPF, Ramirez LC, Arauz-Pacheco C, Lackner C, Albright G, Adams BV, Raskin P . Lipoprotein (a) levels in diabetes mellitus: relationship to metabolic control. Ann Intern Med 1992;117:42–7.
Verrotti A, Lobefalo L, Chiarelli F, Gallenga PE, Morgese G . Diabetic retinopathy: relationship with retinopathy in pediatric age. PanMinerva Med 1994;36:179–83.
Verrotti A, Chiarelli F, Tumini S, Morgese G . Serum lipids, microalbuminuria and metabolic control in diabetic children. Acta Diabetol Lat 1991;28:99–104.
Klein BEK, Davis MD . Diabetic retinopathy: assessment of severity and progression. Ophthalmology 1984;91:10–4.
Verrotti A, Chiarelli F, Morgese G . Influence of puberty on lipids and lipoprotein profile in children with Type 1 diabetes mellitus. Acta Diabetol 1995;32:102–5.
Chiarelli F, Verrotti A, La Penna G, Morgese G . Low serum C4 levels in type 1 diabetes mellitus. Eur J Pediatr 1988;147:197–8.
Mogensen CE, Christensen CK . Predicting diabetic nephropathy in insulin-dependent patients. N Engl J Med 1984;311:89–93.
Winocur PH, Bhatnagar D, Ishola M, Arrol S, Durrington PN . Lipoprotein (a) and microvascular disease in type 1 (insulin-dependent) diabetes. Diabetic Med 1991;8:922–7.
Havel RJ, Eder HA, Bragdon JH . The distribution and chemical composition of ultracentrifugally separated lipoproteins in normal serum. J Clin Invest 1955;34:1345–53.
Durrington PN . Serum high density lipoprotein cholesterol subfractions in type 1 (insulin-dependent) diabetes mellitus. Clin Chim Acta 1982;120:21–8.
Burstein M, Scholnick HR, Morfin R . Rapid method for the isolation of lipoproteins from human serum by precipitation with polyanions. J Lipid Res 1970;11:583–95.
Kostner GM . Apolipoprotein and lipoproteins of human plasma: significance in health and in disease. Adv Lipid Res 1983;20:1–43.
The Diabetes Control and Complications Trial Study Group. The effect of intense treatment of diabetes on the development and progression of long-term complications in insulin-dependent diabetes mellitus. N Engl J Med 1993;329:977–87.
Maser RE, Usher D, Becker DJ, Drash AL, Kuller LH, Orchard TJ . Lipoprotein (a) concentration shows little relationship to IDDM complications in the Pittsburgh Epidemiology of Diabetes Complications study cohort. Diabetes Care 1993;16:755–8.
Ramirez LC, Arauz-Pacheco C, Lackner C, Albright G, Adams BV, Raskin P . Lipoprotein (a) levels in diabetes mellitus: relationship to metabolic control. Ann Intern Med 1992;117:42–7.
Lapolla A, Poli T, Valerio A, Fedele D . Glycosylated serum proteins in diabetic patients and their relation to metabolic parameters. Diabete Metab 1985;11:238–42.
Dornan TL, Carter RD, Bron AJ, Turner RC, Mann JI . Low density lipoprotein cholesterol: an association with the severity of diabetic retinopathy. Diabetologia 1982;22:167–70.
Ritter MM, Loscar M, Richter WO, Schwandt P . Lipoprotein (a) in diabetes mellitus. Clin Chim Acta 1993;214:45–54.
Kostraba JN, Klein R, Dorman JS, Becker DJ, Drash AL, Maser RE, Orchard TJ . The epidemiology of diabetes complications study. IV. Correlates of diabetic background and proliferative retinopathy. Am J Epidemiol 1991;133:381–91.
Klein R, Klein BEK, Moss SE, Davis D, DeMets DL . The Wisconsin Epidemiologic Study of Diabetic Retinopathy. II. Prevalence and risk of diabetic retinopathy when age at diagnosis is less than 30 years. Arch Ophthalmol 1984;102:520–6.
McLean JW, Tomlison JE, Kuang WJ . cDNA sequence of human apolipoprotein (a) is homologous to plasminogen. Nature 1987;300:132–7.
Mbewu AD, Durrington PN . Lipoprotein (a): structure, properties and possible involvement in thrombo-genesis and atherogenesis. Atherosclerosis 1990;85:1–14.
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Verrotti, A., Lobefalo, L., Chiarelli, F. et al. Lipids and lipoproteins in diabetic adolescents and young adults with retinopathy. Eye 11, 876–881 (1997). https://doi.org/10.1038/eye.1997.225
Issue Date:
DOI: https://doi.org/10.1038/eye.1997.225